8-K
Current Report
X4 Pharmaceuticals, Inc Filed Acc 0001628280-23-034547
Executive or director change · Regulation FD disclosure
- Item 5.02 Departure or appointment of directors or officers
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading xfor-20231016.htm…